Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Scientists Find New No-Needle Approach to Prevent Blood Clots

Scientists Find New No-Needle Approach to Prevent Blood Clots

August 12, 2009

The dean of the University of Oklahoma College of Public Health and a team of scientists worldwide have found a better way to prevent deadly blood clots after joint replacement surgery - a major problem that results in thousands of unnecessary deaths each year. The research appears this week in the New England Journal of Medicine.

The research team, which includes scientists from Oklahoma, Denmark, Australia and Canada, set out to find a better way to prevent blood clots without increasing the risk of bleeding. Blood clots, known as deep-vein thrombosis (DVT), affect the large veins in the lower leg and thigh. If the clot breaks free and moves through the bloodstream, it can lodge in the lungs, a condition known as pulmonary embolism (PE), which is often fatal. Pulmonary embolism is the most common preventable cause of sudden death after surgery.




Current preventive treatments include uncomfortable injections and one oral anti-clotting medicine that is difficult for patients and physicians to manage. Researchers wanted to find something better.

In a double-blind study of more than 3,000 patients, researchers tested a new type of anti-clotting drug called Apixaban, which is an oral medication. The medicine proved just as effective at preventing blood clots and reduced the risk of bleeding by half. Most importantly for patient convenience, it was much easier to use.

"This is a major step in our fight to prevent DVT and the many unnecessary deaths each year caused by blood clots after joint replacement surgery. We now have a better treatment that reduces the risk of bleeding, and a patient no longer has to endure injections by needle," said Gary Raskob, Ph.D., a lead researcher on the project and dean of the OU College of Public Health.

Raskob, who is a renowned expert in the field, said as our population ages, the number of hip and knee replacements will skyrocket in the coming years, so an easier to use and safe preventive medicine is essential. According to the American Academy of Orthopaedic Surgeons, more than 700,000 primary total hip and knee replacements are performed each year in the United States, and that number is expected to grow to more than 3.5 million by 2030.

On average, 1 percent to 3 percent of people undergoing total joint replacement will end up with a symptomatic deep-vein thrombosis (blood clot in the legs) or a pulmonary embolism (a blood clot in the lungs).

Apixaban is now being studied in Phase III clinical trials and, if approved by the U.S. Food and Drug Administration, will be an important option for patients having joint replacement surgery.

The University of Oklahoma Health Sciences Center



Related Blood Clots Current Events and Blood Clots News Articles Blood Clots Current Events and Blood Clots News RSS Blood Clots Current Events and Blood Clots News RSS
When seconds count: Interventional radiology treatment for pulmonary embolism saves lives
Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.

Blood test identifies women at risk from Alzheimer's
Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer's many years later, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

Chemo-radiation before prostate removal may prevent cancer recurrence
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival.

Stanford study recommends change in treating pulmonary embolisms
William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics.

Increased stroke risk from birth control pills
She was only 30 years old, but she was experiencing the classic symptoms of a stroke. Her speech suddenly became slurred, and her left hand became clumsy while eating.

Smoking gun: just 1 cigarette has harmful effect on the arteries of young healthy adults
Even one cigarette has serious adverse effects on young adults, according to research presented by Dr. Stella Daskalopoulou at the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Blood clots in lungs might not always originate in deep veins of legs and pelvis in trauma patients
Few trauma patients who develop potentially deadly blood clots in the lungs (pulmonary embolism) also have clots in the deep veins of their pelvis and legs (deep venous thrombosis), challenging commonly held beliefs about the association between the two conditions.

Super sticky barnacle glue cures like blood clots
Barnacles are a big problem for boats. Adhering to the undersides of vessels, carpets of the crustaceans can increase fuel consumption by as much as 25%.

Study details safe, effective, minimally invasive mitral valve repair
Surgical treatment for mitral valve disease includes either repairing the patient's diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve.

Women with Atrial Fibrillation Are at Significantly Higher Risk of Stroke and Death Compared to Men and Receive Less Attention
Even though the incidence of atrial fibrillation is higher in men than women, a review of past studies and medical literature completed by cardiac experts at Rush University Medical Center shows that women are more likely than men to experience symptomatic attacks, a higher frequency of recurrences, and significantly higher heart rates during atrial fibrillation, which increases the risk of stroke.
More Blood Clots Current Events and Blood Clots News Articles
BLOOD CLOT: In Combat with the Patrols Platoon, 3 Para, Afghanistan 2006

BLOOD CLOT: In Combat with the Patrols Platoon, 3 Para, Afghanistan 2006
by Jake Scott (Author)

"As you know 'blood clot' means blood cells coming together to form a strong clot that forms and sticks together to keep the wound sealed enabling it to repair. The Parachute Regiment's 'blood clot' acts the same, whether downtown scrapping or in some far away country fighting alongside each other. Our maroon berets come together, they stick together, they close ranks forming the blood clot and fight against anything that comes their way." (Jake Scott)

When the 3 Para battle group departed for Helmand Province, south Afghanistan, nobody really knew what to expect. Within a month of being on the ground the first of many contacts between the Taliban and British forces began. The British government and media were in shock - for the men on the ground it was what they were trained for....

Celox First Aid Temporary Traumatic Wound Treatment - 15g Pouch

Celox First Aid Temporary Traumatic Wound Treatment - 15g Pouch
by SAMMedical

CELOXTM is the newest generation of emergency hemostatic agents. Simpler to use and safer than older technologies, CELOX granules quickly control even severe arterial bleeding. Just pour it in, pack it, and apply pressure. No specific training is required. CELOX is not exothermic and won't burn the victim or caregiver. And CELOX works in hypothermic conditions and clots Heparinized blood. CELOX is safe to use for the entire body including head, neck and chest wounds. Most importantly, CELOX can be used instantly and without hesitation as a fast, safe and simple emergency treatment for serious bleeding. Average Time to Clot Whole Blood: 30.5 Seconds Average Time to Clot Heparinized Blood: 48 Seconds Controls Major Arterial Bleeding CELOXs unusual properties have been confirmed in wound...

Deadly  Blood Clots: The Dangers of Venous Thromboembolism

Deadly Blood Clots: The Dangers of Venous Thromboembolism

Part of the award winning public television series Healthy Body/Healthy Mind. The dangers of blood clots are well known: they can cause heart attacks, strokes and other potentially fatal conditions. But there's another medical hazard that occurs when the blood clot lives quietly deep in the veins of the legs. And when a part of this blood clot breaks off and travels to the lung the result can be almost instantaneous death. This type of blood clot is called deep vein thrombosis and when it travels to the lungs its called pulmonary embolism. And these are two manifestations of the condition known as venous thromboembolism. In this program we will examine the symptoms and risk factors of venous thromboembolism, see who should be tested for clotting disorders and highlight the latest...

Mr. Blood Clot

Mr. Blood Clot
Dimentia 13 (Primary Contributor)



Silver Star Blood Clot Men's Tee, L, WH

Silver Star Blood Clot Men's Tee, L, WH
by TITLE Boxing

100% Cotton

Z-Med QuikClot - Home (1 pack)

Z-Med QuikClot - Home (1 pack)
by Z-Medica

QuikClot Sport brand hemostatic agent is based on the same QuikClot brand hemostatic agent used by the US military, federal agencies, EMS, police and fire departments everywhere. Remove the QuikClot Sport from the package, apply to the wound using pressure and stop the bleeding fast. QuikClot Sport is ideal for schools, individual and team sports, wilderness medicine and even home use. This product is the perfect size for scalp lacerations or bleeding where a bandage is not enough. Every home first aid kit and sports athletic trainer's first aid kit should contain QuikClot Sport brand hemostatic.

  Deadly Blood Clots: The Dangers Of Venous Thromboembolism
Directed By: Information Television Network



Olympian Labs Nattokinase, 100mg

Olympian Labs Nattokinase, 100mg
by Olympian Labs

Nattokinase is a serine protease type enzyme derived from fermented soybeans. Research has shown nattokinase to support healthy coagulation of blood and enhance fibrinolytic (breaking up of clots) activity. Fibrin is a protein that, when activated, forms fibrinogen which is responsible for blood clotting. OL uses only the highly bioavailable, proprietary extract of natto.

Blood Clots & Strokes: A Guide for Parents & Little Folks

Blood Clots & Strokes: A Guide for Parents & Little Folks
by Maureen Andrew M.D. (Author), Maureen Andrew (Author), Maureen Andrew (Author)

Blood clots occur in children who have major primary illnesses. For many parents, the news of a blood clot is another in a long line of complication. In some children, the clot is a surprise complication which impairs otherwise good recovery. Less commonly, the clot or stroke is a sudden devasting blow to an otherwise well child. Blood Clots and Strokes: A Guide for Parents and Little Folks is formatted as specific questions and answers which allow for quick and easy reference, by the parents. The questions used in the text are those most commonly asked. Blood Clots and Strokes: A Guide for Parents and Little Folks will endeavor to provide parents with an understanding which will enable them to appreciate the need for individual consideration in the care of their children.

Sure Clot - 1/2 ounce

Sure Clot - 1/2 ounce
by BIO DERM

Now you can stop the worry and bleeding caused by accidents or grooming procedures! New Sure Clot is a fast-acting styptic powder and is specially developed to help stop bleeding from clipping nails, docking tails, trimming beaks and other types of minor cuts.

© 2009 BrightSurf.com